NOT-DK-20-026: Notice of Additional Activity Code Accepted for "NOT-DK-20-018, Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIDDK"

Notice of Additional Activity Code Accepted for "NOT-DK-20-018, Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIDDK"

Notice Number:

NOT-DK-20-026

Key Dates

Release Date:

April 27, 2020

Related Announcements

NOT-DK-20-018: Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIDDK

Issued by

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

The purpose of this Notice is to add the U24 activity code to the activity codes eligible for submissions and adjust the language for parent awards to be eligible under NOT-DK-20-018: Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIDDK.

The third and fifth paragraphs under the Application and Submission Information section of NOT-DK-20-018 currently read:

The NIDDK will only accept applications in response to this Notice for the following activity codes: R01, RC2, P01, U2C, UH3, U01, P50, U54, R41, R42, R43, and R44.

To be eligible for this Notice, the parent award to which the revision application is based must:

Be an active NIDDK award that is not in an extension period at the time the revision is awarded, and
Have enough time left in the award to complete the studies proposed after the revision has been awarded

This NOSI is modified to read (with the U24 activity code added):

The NIDDK will only accept applications in response to this Notice for the following activity codes: R01, RC2, P01, U2C, UH3, U01, U24, P50, U54, R41, R42, R43, and R44.

To be eligible for this Notice: The parent award must be active when the supplement/revision application is submitted (e.g. within the originally reviewed and approved project period), regardless of the time remaining on the current project.

All other aspects of NOT-DK-20-018 remain unchanged.

Inquiries

Please direct all inquiries to:

Scientific/Research Contact(s)

Ivonne H. Schulman
Division of Kidney, Urologic and Hematologic Diseases (DKUH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: (301) 385-5744
Email: [email protected]

Christine Lee
Division of Diabetes, Endocrinology and Metabolic Diseases (DEM)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: (301) 594-8806
Email: [email protected]

Peter Perrin
Division of Digestive Diseases and Nutrition (DDN)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: (301) 451-3759
Email: [email protected]